Metfodiab 850 mg Actavis
€28.00
Discover Metfodiab 850 mg Actavis: Your Key Antihyperglycemic Agent
Metfodiab 850 mg Actavis is a highly effective antihyperglycemic agent designed to manage blood sugar levels in individuals with type 2 diabetes. Utilising the active substance Metformin Hydrochloride, this formulation works by reducing hepatic glucose production and enhancing insulin sensitivity, facilitating optimal glucose uptake and utilisation in the body. With a dosage typically starting at 850 mg once a day, Metfodiab offers tailored management for those seeking to stabilise their blood sugar levels.
Advantages of Metfodiab: Elevate Your Health Naturally
The use of Metfodiab 850 mg Actavis comes with numerous advantages that contribute to a healthier lifestyle. While effectively managing blood glucose levels, Metfodiab also brings along key health benefits that enhance overall well-being.
By choosing this product, you can expect to experience:
- Reduced hepatic glucose production, crucial for managing diabetes
- Improvement in insulin sensitivity, promoting greater glucose absorption
- Minimal risk of water retention, helping maintain a healthy body weight
- Low risk of hepatotoxicity, making it safer for long-term use
This unique combination of effects not only promotes metabolic health but also contributes to your overall quality of life.
Long-Term Benefits of Using Metfodiab 850 mg Actavis
Incorporating Metfodiab 850 mg Actavis into your daily routine can yield profound long-term benefits. With consistent use, this medication not only stabilises blood glucose levels but may also lead to enhancements in cardiovascular health. Some users have reported a slight reduction in blood pressure, further supporting heart health.
Additionally, because Metfodiab has a half-life of approximately 6.2 hours, it offers steady control over glucose fluctuations, allowing you to maintain energy levels throughout the day. Moreover, by monitoring renal function and serum electrolytes, health professionals can ensure safe ongoing use, thus reducing the risk of complications associated with diabetes.
Ultimately, choosing Metfodiab 850 mg Actavis is about embracing a sustainable approach to managing your health. Enjoy the benefits of a product that not only meets immediate needs but supports long-term wellness and vitality. By integrating this therapy into your lifestyle, you’re investing in a healthier future.
| Active substance | Metformin Hydrochlorid |
|---|---|
| Water Retention | Does not cause significant water retention |
| Hepatotoxicity | Low risk |
| Lab Test | Monitoring of renal function and serum electrolytes recommended |
| Also known as | Metformin HCL |
| Blood pressure | Can lead to a slight reduction in blood pressure |
| Trade name | Glucophage, Glumetza, others |
| Storage conditions | Store at room temperature away from moisture and light |
| Chemical name | Metformin hydrochloride |
| Formula | C4H11N5В·HCl |
| Substance class | Biguanide |
| Main action | Antihyperglycemic agent |
| Half-life | Approximately 6.2 hours |
| Dosage (medical) | Typically starting at 500 mg twice a day or 850 mg once a day, up to a maximum of 2000-2550 mg per day depending on the patient's response and tolerance |
| Dosage (sports) | Not typically prescribed for sports enhancement |
| Effects | Reduces hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization |
| Side effects | Gastrointestinal disturbances (such as diarrhea, nausea, vomiting), vitamin B12 deficiency, lactic acidosis (rare but serious) |
| Use in sports | Not commonly used as a performance enhancer, but some athletes might use it for weight management |
| Active ingredient, mg | 850 |
| Release form | Pills |
| 1 Pill, mg | 850 |
| Manufacturer | Actavis |
| Packing | Package (30 Pills) |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.